Skip to content

Clinical trials

Phase 3 Parkinson Disease trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 3 Country / region: Germany Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20033
20044
20051
20065
20076
20082
20093
20104
20111
20131
20146
20154
20162
20183
20196
20203
20211
20222
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48
Terminated8
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie6
UCB Pharma6
Impax Laboratories, LLC5
Adamas Pharmaceuticals, Inc.4
Boehringer Ingelheim3
Theravance Biopharma3
AbbVie (prior sponsor, Abbott)2
GlaxoSmithKline2
Intec Pharma Ltd.2
Kyowa Kirin Co., Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease60
Parkinsonian Disorders10
Dyskinesias9
Brain Diseases4
Central Nervous System Diseases4
Movement Disorders4
Nervous System Diseases4
Neurodegenerative Diseases4
Dizziness3
Hypotension3

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.